Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

183
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
183
Vaccinations01:51

Vaccinations

44.6K
Overview
44.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

339
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
339
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

246
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
246
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

243
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
243
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

144
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
144

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers and Facilitators to ICU Liberation Bundle Implementation and Compliance.

Critical care explorations·2026
Same author

The Impact of Centrally Acting Drug Burden at Discharge on Long-Term Outcomes Among ICU Survivors.

Critical care medicine·2026
Same author

In Search of a Healing Environment, Are We Looking Through the Right Window?

Critical care medicine·2025
Same author

Optimal Sedation in Older Critically Ill Adults.

Critical care clinics·2025
Same author

Traumatic Hemorrhagic Lung Injury With Pelvic and Femur Fractures Requiring Resuscitative Balloon Occlusion of the Aorta, Operative Fixation on Dual-Circuit Venous Extracorporeal Membrane Oxygenation, and Systemic Isoflurane Sedation.

Chest·2025
Same author

Management of pain and sedation in the intensive care unit.

BMJ (Clinical research ed.)·2024
Same journal

Pulmonary fibrosis in chILD: bridging the gap.

The Lancet. Respiratory medicine·2026
Same journal

Heterogeneity of severe asthma in Europe: a SHARP-er view.

The Lancet. Respiratory medicine·2026
Same journal

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same journal

Prevalence and disease trajectories of pulmonary fibrosis of childhood interstitial lung disease: a register-based, multicentre observational study.

The Lancet. Respiratory medicine·2026
Same journal

Correction to Lancet Respir Med 2026; published online May 28. https://doi.org/10.1016/S2213-2600(26)00160-8.

The Lancet. Respiratory medicine·2026
Same journal

Trump Administration sparks furore and resignations over fruit-flavoured vape authorisations.

The Lancet. Respiratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jul 12, 2025

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3
07:35

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3

Published on: April 13, 2009

8.2K

Discussions on VT4COVID

Christina Boncyk1, Katarzyna Kotfis2, E Wesley Ely3

  • 1Department of Anesthesiology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN 37212, USA; Critical Illness, Brain Dysfunction, and Survivorship Center, Nashville, TN, USA.

The Lancet. Respiratory Medicine
|November 1, 2023
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems
09:28

Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems

Published on: November 4, 2014

112.6K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.8K

Related Experiment Videos

Last Updated: Jul 12, 2025

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3
07:35

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 3

Published on: April 13, 2009

8.2K
Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems
09:28

Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems

Published on: November 4, 2014

112.6K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.8K